First-line maintenance therapy with niraparib in advanced platinum-sensitive ovarian cancer: two ‘long responder’ case reports and review of the current literature

The standard of care for newly diagnosed advanced ovarian cancer is surgical cytoreduction plus platinum-based chemotherapy; however, recurrent disease frequently occurs after treatment. Poly(ADP-ribose) polymerase (PARP) inhibitors as first-line maintenance therapy have been demonstrated to signifi...

Descripción completa

Detalles Bibliográficos
Autor principal: Ngan, Roger K. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492491/
https://www.ncbi.nlm.nih.gov/pubmed/37676922
http://dx.doi.org/10.1177/03000605231194881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492491/
https://www.ncbi.nlm.nih.gov/pubmed/37676922
http://dx.doi.org/10.1177/03000605231194881

Ejemplares similares